Paper26314773
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Tilly H and 11 others. Ann Oncol, 2015. Cited by 684 papers, by iCite.
Cite this record
ConductScience Library. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Papers, record 26314773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26314773
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- PubMed
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| Humans |
Source PubMed
Cited by398
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 684 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972012 | The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma. | Leukemia | 2026 | https://conductscience.org/library/papers/42972012 | PubMed |
| 42958392 | Economic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis. | Cost Eff Resour Alloc | 2026 | https://conductscience.org/library/papers/42958392 | PubMed |
| 42938188 | PD-L1 Expression and Clinicopathologic Associations in Mediastinal Aggressive Large B-Cell Lymphomas: A Retrospective Single-Center Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42938188 | PubMed |
| 42909844 | Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United States. | Adv Ther | 2026 | https://conductscience.org/library/papers/42909844 | PubMed |
| 42795255 | Late-Onset Neutropenia and Hypogammaglobulinemia After Dose-Adjusted R-EPOCH in Unfavorable Diffuse Large B-Cell Lymphoma. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42795255 | PubMed |
| 42682433 | Early identification of high-risk myelosuppression subtypes in DLBCL patients undergoing R-CHOP chemotherapy. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42682433 | PubMed |
| 42661655 | Case Report: Non-traumatic splenic rupture as the first presentation of diffuse large B-cell lymphoma complicated by clinically diagnosed pulmonary aspergillosis supported by metagenomic next-generation sequencing. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42661655 | PubMed |
| 42564436 | Array comparative genomic hybridisation in haematological malignancies: A comprehensive review. | Afr J Lab Med | 2026 | https://conductscience.org/library/papers/42564436 | PubMed |
| 42558389 | Patient-derived organoids in functional precision oncology: from experimental models to clinical decision-making. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42558389 | PubMed |
| 42544236 | Cellular Immunity Profile in B-Cell Non-Hodgkin Lymphoma Patients Receiving Rituximab-Based Chemotherapy. | J Blood Med | 2026 | https://conductscience.org/library/papers/42544236 | PubMed |
| 42355593 | Precision Medicine in Non-Hodgkin Lymphoma: Advances in BTK Inhibition, CD30-Directed Antibody-Drug Conjugates, and HDAC-Mediated Epigenetic Therapy with Pirtobrutinib, Brentuximab Vedotin, and Belinostat. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355593 | PubMed |
| 42261338 | Healthy birth after chemotherapy for diffuse large B-cell lymphoma with superior vena cava syndrome in late pregnancy: A case report. | SAGE Open Med Case Rep | 2026 | https://conductscience.org/library/papers/42261338 | PubMed |
| 42217135 | Understanding Physician Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. | J Cancer Educ | 2026 | https://conductscience.org/library/papers/42217135 | PubMed |
| 42192915 | Bradyarrhythmias Associated with Oncologic Treatment-An Updated Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42192915 | PubMed |
| 42109979 | New Diagnosis of B-cell Follicular Lymphoma Temporally Associated With Routine Vaccination: A Report of Two Cases. | Cureus | 2026 | https://conductscience.org/library/papers/42109979 | PubMed |
| 42045678 | Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42045678 | PubMed |
| 41973274 | Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems? | EJNMMI Phys | 2026 | https://conductscience.org/library/papers/41973274 | PubMed |
| 41849017 | Improved outcomes of fluorescence-guided laparoscopic lymph node biopsy vs. conventional laparoscopic technique in lymphoma diagnosis. | Updates Surg | 2026 | https://conductscience.org/library/papers/41849017 | PubMed |
| 41843321 | Application value of gastric contrast ultrasonography in gastric tumors. | Insights Imaging | 2026 | https://conductscience.org/library/papers/41843321 | PubMed |
| 41835908 | Cost-utility Analysis of R-CHOP vs CHOP in Patients with Non-Hodgkin's Lymphoma: A Systematic Review. | Acta Med Philipp | 2026 | https://conductscience.org/library/papers/41835908 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26314773
GET https://conductscience.org/api/papers/v1/26314773/cited_by?page=2